AIG
THRN

American International Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

American International Group’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,008
Closed -$71.4K – 3067
2023
Q3 		$71.4K Buy
7,008
+249
+4% +$1.9K ﹤0.01% 2695
2023
Q2 		$31.8K Buy
6,759
+27
+0.4% +$124 ﹤0.01% 2965
2023
Q1 		$31.1K Buy
6,732
+228
+4% +$1K ﹤0.01% 2822
2022
Q4 		$23.6K Sell
6,504
-24
-0.4% -$106 ﹤0.01% 2904
2022
Q3 		$31K Buy
6,528
+92
+1% +$462 ﹤0.01% 2929
2022
Q2 		$31K Buy
6,436
+3,103
+93% +$18.9K ﹤0.01% 2962
2022
Q1 		$21K Sell
3,333
-236
-7% -$1.27K ﹤0.01% 3022
2021
Q4 		$22K Buy
+3,569
New +$27.9K ﹤0.01% 3080

American International Group's THRN Position: Q4 2023 in Review

American International Group sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 7,008 shares — an estimated $71.4K sold.

American International Group first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $71.4K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • American International Group reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • American International Group sold 7,008 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $71.4K.
  • American International Group first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • American International Group's Thorne Healthtech, Inc. Common Stock position peaked at $71.4K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on American International Group's 13F filing for Q4 2023, filed 13 Feb 2024.